LifeTech Scientific Files Director List with HKEX

Reuters
Jan 26
LifeTech Scientific Files Director List with HKEX

LifeTech Scientific Corporation has released an updated list of directors and their roles, as filed with the Hong Kong Stock Exchange. The Board comprises Executive Directors Xie Yuehui (Chairman and CEO), Liu Jianxiong (Executive Vice President, CFO, and Company Secretary), Wu Liping, Fang Yu, and Feng Xiaoling. Jiang Feng serves as Non-executive Director, while Zhou Luming and Chen Dongxia are Independent Non-executive Directors. Committee memberships were also disclosed: the Audit Committee is chaired by Chen Dongxia, with Zhou Luming as a member; the Remuneration Committee is chaired by Chen Dongxia, with Xie Yuehui, Feng Xiaoling, and Chen Dongxia as members; the Nomination Committee is chaired by Zhou Luming, with Xie Yuehui and Chen Dongxia as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeTech Scientific Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260126-12001173), on January 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10